Photobiomodulation Autism Trial for Children, NCT07542899
Summary
NIH has registered a new clinical trial (NCT07542899) evaluating photobiomodulation therapy on core symptoms of autism spectrum disorder in children. The study will combine photobiomodulation with physical therapy, occupational therapy, and speech therapy over a defined treatment period. Outcomes will be measured using standardized clinical scales assessing social interactions, communication, and behavior improvements.
What changed
NIH has registered a new ClinicalTrials.gov entry for a study evaluating photobiomodulation therapy as an intervention for autism spectrum disorder in pediatric participants. The study will enroll children receiving combined photobiomodulation and rehabilitative therapies, with outcomes assessed using standardized clinical scales for social interaction, communication, and behavioral measures. For clinical research organizations and healthcare institutions conducting autism-related trials, this registration indicates ongoing investigation into non-pharmacological therapeutic approaches for pediatric autism interventions.
Affected parties include clinical investigators specializing in developmental disorders, pediatric research facilities, and autism treatment centers considering photobiomodulation as a treatment modality. Sponsors of similar autism intervention studies should monitor this trial's outcomes as preliminary data may influence future research directions in neuromodulation therapies for pediatric populations.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Photobiomodulation on Core Symptoms of Autism
N/A NCT07542899 Kind: NA Apr 21, 2026
Abstract
This study aims to evaluate the effectiveness of photobiomodulation therapy on core symptoms in children with autism spectrum disorder. Participants will receive designed physical therapy, occupational therapy and speech program in addition to Photobiomodulation over a defined period. Out comes will be assessed using standardized clinical scales to determine improvements in social interactions, communication and behavior.
Conditions: Autism
Interventions: Photobiomodulation
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.